We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

603288:SSEFoshan Haitian Flavouring and Food Company Ltd. Class A Analysis

Data as of 2026-05-29 - not real-time

CN¥35.85

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Foshan Haitian is trading at CNY 35.85, which is more than double the DCF‑derived fair value of CNY 16.49, indicating a substantial overvaluation. Revenue growth of 8.6% YoY and a solid gross margin of 40% underpin a healthy earnings profile, while the company delivers a dividend yield of 3.17% with a high payout ratio near 90%. The technical picture is mixed: the 14‑day RSI sits at 34.9, suggesting mild oversold pressure, but the MACD histogram is negative and the MACD signal is bearish, with price hovering just above the identified support of CNY 34.88. Volatility over the past 30 days is 15.5%, yet the beta of 0.15 signals very low market‑wide sensitivity, reflecting the defensive nature of the packaged‑foods sector. The balance sheet is strong, featuring CNY 30.9 bn in cash against modest debt of CNY 0.37 bn, and free cash flow of CNY 3.47 bn supports the dividend stream. In summary, while the fundamentals and cash generation are robust, the current price premium and bearish short‑term technical signals suggest caution, with the dividend offering a modest cushion for income‑focused investors.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD and negative histogram
  • Price significantly above DCF fair value
  • Technical support proximity with limited upside

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Consistent revenue growth and strong margins
  • Stable dividend yield of 3.17%
  • Low beta and defensive sector positioning

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust cash generation and low leverage
  • Defensive consumer staple business with export potential
  • Attractive dividend yield and potential price correction toward intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin24.61%
P/E Ratio28.7
ROE19.13%
ROA11.65%
Debt/Equity0.87
P/B Ratio5.0
Op. Cash FlowCN¥7.7B
Free Cash FlowCN¥3.5B

Technical Analysis

TrendNeutral
RSI34.9
SupportCN¥34.88
ResistanceCN¥39.79
MA 20CN¥36.94
MA 50CN¥38.68
MA 200CN¥38.19
MACDBearish
VolumeStable
Fear & Greed Index93.32

Valuation

Fair ValueCN¥16.49
GradeOvervalued
TypeBlend
Dividend Yield3.17%

Risk Assessment

Beta0.05
Volatility15.48%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.